Antimicrobial Peptides and Their Modified Analogues: Properties and Research

The increasing prevalence of antibiotic resistance is one of the major challenges facing modern medicine. Inappropriate or excessive use of antimicrobial drugs has contributed to reduced effectiveness and the emergence of resistant microorganisms.
Current research is therefore exploring alternative strategies that may act against pathogenic microorganisms through naturally occurring defense mechanisms. One area of growing scientific interest involves antimicrobial peptides (AMPs) and modified analogues designed to improve their stability, activity, and biological properties.
Keywords: antimicrobial peptides, AMP, antimicrobial resistance, chemical modifications, cyclization, drug conjugates, lipidation
Abbreviation: AMP – antimicrobial peptide
The Concept of Drug Resistance
Drug resistance refers to the ability of microorganisms or parasites to survive or reproduce despite exposure to a substance that would normally inhibit their growth or cause their destruction.
Drug resistance can generally be divided into two categories:
-
Innate resistance, which occurs naturally in certain microorganisms.
-
Acquired resistance, which develops after exposure to antimicrobial agents and may involve genetic changes that reduce susceptibility to a particular drug.
The increasing occurrence of acquired antimicrobial resistance has encouraged researchers to investigate alternative compounds and biological mechanisms that could support future antimicrobial strategies.
Antimicrobial Peptides – Characteristics
Antimicrobial peptides, commonly referred to as AMPs, are a diverse group of naturally occurring peptides involved in the defense mechanisms of many organisms.
AMPs commonly contain approximately 10–50 amino acid residues. Many possess a positive net charge, often associated with amino acids such as L-arginine, L-lysine, or L-histidine.
AMPs can be produced through two principal pathways:
-
Ribosomal synthesis, involving mRNA translation and occurring throughout many living organisms.
-
Non-ribosomal peptide synthesis, which is particularly common among microorganisms such as bacteria.
Non-ribosomal peptides include compounds related to antimicrobial agents such as polymyxins and gramicidin S.
Ribosomally synthesized antimicrobial peptides have also attracted considerable scientific interest because of their role in innate immunity and natural defense systems.
AMPs have been identified in animals, plants, microorganisms, and other biological sources.
Defensins as Animal Antimicrobial Peptides
A large number of antimicrobial peptides have been identified in fish, amphibians, mammals, and other animals.
In mammals, AMPs can be found in cells involved in immune defense, including neutrophils and macrophages, as well as in secretions produced by epithelial tissues.
Among the most extensively studied antimicrobial peptides are defensins.
Defensins are amphipathic peptides rich in basic amino acids and cysteine residues. They occur in both animals and plants and have been investigated for their activity against various microorganisms.
Three major classes of defensins are generally distinguished:
-
α-defensins
-
β-defensins
-
θ-defensins
These groups differ primarily in the arrangement and topology of their disulfide bridges.
Examples of α-defensins include HNP1–4 and the peptides HD5 and HD6. These peptides have been identified in different tissues and mucosal surfaces.
β-defensins represent a particularly diverse class of antimicrobial peptides and have been identified across numerous vertebrate species.
θ-defensins include peptides such as RTD1–3 and have also been investigated for antimicrobial properties.
Experimental research suggests that different defensins may interact with Gram-positive bacteria, Gram-negative bacteria, fungi, and other microorganisms through several biological mechanisms.
Plant Antimicrobial Peptides
Antimicrobial peptides are also widely distributed throughout the plant kingdom.
A characteristic feature of many plant AMPs is the presence of cysteine residues and multiple disulfide bridges. These structural features help produce compact peptide conformations and may contribute to resistance against chemical and proteolytic degradation.
Important groups of plant antimicrobial peptides include:
-
Thionins
-
Defensins
-
Cyclotides
Many of these peptides contain approximately 45–50 amino acid residues.
Thionins can be divided into different structural subgroups depending on the number and arrangement of cysteine residues and disulfide bonds.
These naturally occurring peptide structures continue to serve as models for research into antimicrobial compounds and modified peptide analogues.
Properties of Antimicrobial Peptides
Antimicrobial peptides are being studied as potential tools in addressing antimicrobial resistance.
Research has demonstrated that certain AMPs can exhibit activity against different types of microorganisms, including:
-
Gram-positive bacteria
-
Gram-negative bacteria
-
Certain fungi
-
Some viruses
Depending on the individual peptide and experimental model, AMPs have also been investigated for their potential influence on bacterial toxins, biofilm formation, inflammatory signaling, and tissue-repair processes.
However, the biological activity, effectiveness, toxicity, stability, and potential clinical applications of antimicrobial peptides vary considerably between different compounds.
How Antimicrobial Peptides Interact With Microbial Membranes
One of the best-studied mechanisms of antimicrobial peptides involves interactions with microbial cell membranes.
Many bacterial membranes contain negatively charged components. Positively charged regions of certain AMPs may therefore interact with these membranes through electrostatic and hydrophobic forces.
These interactions can disrupt membrane integrity and interfere with normal cellular processes.
Several models have been proposed to explain how antimicrobial peptides interact with microbial membranes.
1. Barrel-Stave Model
In the barrel-stave model, amphipathic peptides interact with the bacterial membrane and arrange themselves in a way that can create transmembrane pores or channels.
The hydrophobic regions of the peptides interact with membrane lipids, while hydrophilic regions face toward the inside of the pore.
This may disrupt membrane potential, ion balance, and membrane permeability.
2. Carpet Model
In the carpet model, peptide molecules accumulate across the surface of the microbial membrane.
Their hydrophilic regions interact with polar membrane components, while hydrophobic regions interact with the lipid layer.
Once a sufficient concentration of peptide molecules is reached, membrane organization may become destabilized, ultimately contributing to membrane disruption.
3. Toroidal Pore Model
The toroidal pore model involves peptide accumulation on the lipid bilayer followed by bending of the membrane.
Both peptide molecules and lipid head groups may participate in forming pores within the membrane.
This mechanism differs structurally from the barrel-stave model because the lipid membrane itself contributes directly to the pore architecture.
Chemical Modification of Antimicrobial Peptides
Although naturally occurring antimicrobial peptides have many interesting biological properties, their practical application can be limited by factors such as:
-
Enzymatic degradation
-
Limited stability
-
Bioavailability
-
Toxicity at certain concentrations
-
Production costs
For these reasons, researchers are developing synthetic AMP analogues based either on natural antimicrobial peptides or on specific peptide sequences responsible for antimicrobial activity.
Several modification strategies are currently being studied.
1. Cyclization
Cyclization involves creating additional connections within a peptide chain to produce a more constrained molecular structure.
Cyclization can occur between:
-
The N- and C-terminal ends of a peptide
-
One peptide terminus and an amino-acid side chain
-
Different amino-acid side chains
A major purpose of cyclization is to improve peptide stability and increase resistance to degradation by proteolytic enzymes.
Studies of cyclized AMP analogues have reported changes in antimicrobial activity against various microorganisms, including selected strains of:
-
Escherichia coli
-
Bacillus subtilis
-
Staphylococcus aureus
-
Enterococcus faecalis
-
Pseudomonas aeruginosa
-
Klebsiella pneumoniae
Research continues to investigate how cyclization can improve peptide stability while maintaining desirable biological activity.
2. Drug Conjugates
Another approach involves linking antimicrobial peptides to other therapeutic molecules, including antibiotics.
Such peptide-drug conjugates are being investigated as a way of modifying antimicrobial activity, targeting, pharmacological properties, and potentially required drug concentrations.
Experimental studies have examined AMP conjugates against microorganisms such as E. coli, B. subtilis, and various staphylococcal strains.
The biological activity and safety of these conjugates depend strongly on their molecular structure and therefore require individual evaluation.
3. Lipidation
Lipidation involves attaching lipid groups or fatty-acid chains to a peptide molecule.
This modification can change several characteristics of a peptide, including:
-
Affinity for cell membranes
-
Water solubility
-
Self-organization
-
Thermal stability
-
Biological activity
The properties of a lipidated peptide depend on factors such as the type of fatty acid used and the length of the attached carbon chain.
Lipidated AMP analogues have been studied against microorganisms including selected Gram-positive and Gram-negative bacteria, as well as fungi such as Candida species.
These findings have made lipidation an important research strategy in the development of modified antimicrobial peptides.
Summary
Antimicrobial resistance remains an important challenge for modern medicine and has increased scientific interest in alternative antimicrobial strategies.
Antimicrobial peptides form part of the natural defense systems of many organisms and represent a diverse group of molecules capable of interacting with microorganisms through several mechanisms.
However, natural AMPs may have limitations involving stability, bioavailability, production costs, and other pharmacological characteristics.
For this reason, researchers are investigating modified peptide analogues using approaches such as cyclization, drug conjugation, and lipidation.
These modifications may help improve selected properties of antimicrobial peptides, but their effectiveness and safety depend on the individual compound and require appropriate laboratory and clinical evaluation.
Overall, antimicrobial peptides and their modified analogues remain an active area of research in the search for new approaches to antimicrobial resistance.
Explore related products in our Research Peptides collection.
Read also
- Peptide Synthesis, Modification & Characterization
- What Are Peptides Used For? Uses & Research
- BPC-157 Peptide: Research, Mechanisms & Evidence
Bibliography
-
Veltri D, Kamath U, Shehu A. Deep learning improves antimicrobial peptide recognition. Bioinformatics. 2018;34:2740–2747.
-
Manzini MC, Perez KR, Riske KA, et al. Peptide ratio and membrane surface charge determine the mechanism of action of the antimicrobial peptide BP100. Biochimica et Biophysica Acta. 2014;1838:1985–1999.
-
Agrawal P, Raghava GPS. Prediction of antimicrobial potential of a chemically modified peptide from its tertiary structure. Frontiers in Microbiology. 2018;9:2551. doi:10.3389/fmicb.2018.02551.
-
Usmani SS, Bedi G, Samuel JS, et al. THPdb: Database of FDA-approved peptide and protein therapeutics. PLOS ONE. 2017. doi:10.1371/journal.pone.0181748.
-
Xiao Y, Hughes AL, Ando J, et al. A genome-wide screen identifies a single β-defensin gene cluster in the chicken: implications for the origin and evolution of mammalian defensins. BMC Genomics. 2004;5:56. doi:10.1186/1471-2164-5-56.
This article is for educational purposes only and does not replace medical advice. The studies described concern the substances, not finished products.
More in Peptide Science
Not sure where to start?
3 quick questions. We’ll show you where to start and what it costs.




